Camber Capital Management as of Dec. 31, 2017
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 34 positions in its portfolio as reported in the December 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 19.6 | $400M | 1.5M | 266.86 | |
| Nektar Therapeutics (NKTR) | 9.8 | $200M | 3.4M | 59.72 | |
| Hca Holdings (HCA) | 5.4 | $110M | 1.3M | 87.84 | |
| Mylan Nv | 5.2 | $106M | 2.5M | 42.31 | |
| Allergan | 4.8 | $98M | 600k | 163.58 | |
| Universal Health Services (UHS) | 4.3 | $88M | 780k | 113.35 | |
| Tenet Healthcare Corporation (THC) | 4.3 | $87M | 5.8M | 15.16 | |
| Envision Healthcare | 4.2 | $86M | 2.5M | 34.56 | |
| Genomic Health | 4.1 | $84M | 2.5M | 34.20 | |
| Tesaro | 3.5 | $70M | 850k | 82.87 | |
| Brookdale Senior Living (BKD) | 3.1 | $63M | 6.5M | 9.70 | |
| Bioverativ Inc Com equity | 2.9 | $59M | 1.1M | 53.92 | |
| Teva Pharmaceutical Industries (TEVA) | 2.8 | $57M | 3.0M | 18.95 | |
| GlaxoSmithKline | 2.6 | $53M | 1.5M | 35.47 | |
| EXACT Sciences Corporation (EXAS) | 2.6 | $53M | 1.0M | 52.54 | |
| Myriad Genetics (MYGN) | 2.5 | $52M | 1.5M | 34.35 | |
| Medicines Company | 2.1 | $44M | 1.6M | 27.34 | |
| Endologix | 2.1 | $43M | 8.0M | 5.35 | |
| Clovis Oncology | 2.0 | $41M | 600k | 68.00 | |
| AMAG Pharmaceuticals | 1.7 | $35M | 2.7M | 13.25 | |
| Radius Health | 1.6 | $32M | 1.0M | 31.77 | |
| Global Blood Therapeutics In | 1.5 | $32M | 800k | 39.35 | |
| Orthofix International Nv Com Stk | 1.3 | $27M | 500k | 54.70 | |
| Alkermes (ALKS) | 1.1 | $22M | 400k | 54.73 | |
| Invitae (NVTAQ) | 1.1 | $22M | 2.4M | 9.08 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $17M | 300k | 55.64 | |
| K2m Group Holdings | 0.8 | $15M | 850k | 18.00 | |
| Wright Medical Group Nv | 0.6 | $13M | 575k | 22.20 | |
| Atara Biotherapeutics | 0.5 | $9.7M | 536k | 18.10 | |
| Dicerna Pharmaceuticals | 0.4 | $9.0M | 1.0M | 9.03 | |
| BioScrip | 0.4 | $7.4M | 2.5M | 2.91 | |
| Prothena (PRTA) | 0.2 | $4.7M | 125k | 37.49 | |
| Mallinckrodt Pub | 0.1 | $2.4M | 105k | 22.56 | |
| Surgery Partners (SGRY) | 0.1 | $1.6M | 135k | 12.10 |
